The Investment Column: LIG strategy paying off
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.THE MARKET has gradually been warming to London International Group, the Durex condom maker. LIG shares have risen by nearly 40 per since the interim figures last November as the City has responded to the strategy of slimming the group down to concentrate on so-called "barrier" products such as condoms and latex gloves.
Medical products such as its gripe water and Buttercup syrup brands have long gone. And the process continued during the last year with the sale of Cook Bates, the American manicure implements company, which involved taking a pounds 12m exceptional charge.
Nick Hodges, chief executive, now reckons the shape of the business is right with a small health and beauty business in markets like Spain and Italy where the sales forces are useful to help sell the group's condoms.
LIG's investments are starting to pay off and Mr Hodges easily beat his target of improving sales, profits and earnings by 10 per cent a year after only just scraping over the line in November. Operating profit before exceptionals rose by 12.3 per cent to pounds 46.7m and earnings rose by more than 17 per cent.
In condoms the new Avanti polyurethane products are the big thing. Selling at three times the prices of standard latex ranges, the company is now claiming 11 per cent of the UK market with strong sales in Italy and Germany.
More acquisitions are on the agenda, particularly in the Far East where LIG is keen to expand. Though it has a business in Indonesia, bought last year, it says it has been unaffected by the troubles there.
On CSFB's current year forecast of pounds 47m the shares - up 15.5p to 212.5p yesterday - trade on a forward rating of 22. Not cheap, but with strong earnings growth the shares look good value up to 250p.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments